STADA ARZNEIMITTEL |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-1.95% | -8.87% |
| 2023 | Alvotech, Stada Get EU Panel Backing for Stelara Biosimilar | MT |
| 2021 | Sanofi Divests 16 Brands From European Consumer Healthcare Portfolio | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 5.73B | - | - | - | - | - | |
| 44.12B | ||||||
| 22.61B | ||||||
| 15.11B | ||||||
| 13.61B | ||||||
| 13.34B |
- Stock Market
- Equities
- SAZ Stock
- Charts STADA Arzneimittel
- Sector Chart
